Assessment of Cytomorphological Features and Risk of Malignancy of Bethesda Category III in Thyroid Cytopathology. (2025). Journal of Pathology of Nepal, 15(1), 2314-2319. https://doi.org/10.3126/jpn.v15i1.81765